Final global conference “Common strategy on research of ME/CFS”
FINAL Program
12 March 2020 |
|
|
8.45 – 9.15 |
Registration |
|
9.15 – 9.25 |
Opening Remarks and Welcome Modra Murovska, COST Action Chair Ilmārs Stonāns, Head of Research Strategy, RSU Maija Bundule, COST National coordinator, Latvia |
|
SESSION 1 - ME/CFS epidemiology Chair: Eliana Lacerda
|
|
|
9.25 – 9.50 |
Fernando Estévez-López Epidemiology of ME/CFS in Europe: past, present and future |
|
9.50 – 10.30 |
Katherine S. Rowe What do young people find helpful in their management? Findings from a long term follow up study of 784 young people |
|
10.30 – 10.45 |
Joanna Słomko, Pawel Zalewski Prevalence and characteristics of CFS/ME in Poland |
|
10.45 - 11.00 |
Kathleen Mudie Considerations of ME/CFS biobanks and bio-repositories within EUROMENE |
|
11.00 – 11.15 |
Henrik Nielsen HYPOTESIS: We underestimate the risk of chemicals in water and food in ME/CFS |
|
11.15 – 11.45 |
Coffee Break |
|
SESSION 2 - ME/CFS socio-economics Chair: Derek Pheby/Uldis Berķis
|
|
|
11.45 – 12.05 |
Derek Pheby/Uldis Berķis Problems in determining the economic impact of ME/CFS in Europe |
|
|
Uldis Berķis Recommendations of the working group on the development of a Europe-wide consensus approach to the economic evaluation of ME/CFS; questions and answers |
|
12.05 – 12.30 |
Diāna Arāja Investigating the availability of data on ME/CFS patients in Latvia |
|
12.30 – 14.00 |
Lunch |
|
SESSION 3 - ME/CFS biomarkers Chair: Modra Murovska
|
|
|
14.00 - 14:15 |
Carmen Scheibenbogen Biomarker in ME/CFS |
|
14.15 – 14.30 |
Carmen Scheibenbogen Marker for Autoimmunity in ME/CFS |
|
14:30 – 14.45
|
Evelina Shikova-Lekova Chronic viral infections and ME/CFS |
|
15.45 – 15.00 |
Bhupesh Prusty HHV-6 reactivation mimics mitochondrial fragmentation phenotype as seen in the serum of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) patients |
|
18.00 - 21.00 |
Dinner |
|
13 March 2020 |
|
|
SESSION 4 - ME/CFS clinical research Chair: Jerome Authier/Eliana Lacerda
|
|
|
10.00 – 10.15 |
Eliana Mattos Lacerda Diagnostic criteria for Myalgic Encephalomyelitis or Chronic Fatigue Syndrome (ME/CFS) – Recommendations from the EUROMENE’s Clinical Working Group
|
|
10.15 – 10.30 |
Shennae O’Boyle How Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Progresses: The Natural History of ME/CFS
|
|
10.30 – 10.45 |
Caroline Kingdon Including the housebound patient severely affected by ME/CFS in research: a compassionate approach
|
|
10.45 - 11.15 |
Coffee break |
|
11.15 – 11.30 |
Sławomir Kujawski The impact of whole-body cryotherapy upon cognitive function in myalgic encephalomyelitis/chronic fatigue syndrome patients. Preliminary studies
|
|
11.30 – 12.00 |
Šimons Svirskis Cost innovation grant (CIG) application “App and web platform for ME/CFS patients self-empowerment and disease management”
|
|
12.00 – 12.15 |
Closing remarks and farewell |
|
12.15 – 13.30 |
Lunch |
|
13.30 – 18.00 |
Management Committee meeting |
|